Suicide prevention in medical rehabilitatio

• Conditions: I00-I99; M00-M99; Diseases of the circulatory system; Diseases of the musculoskeletal system and connective tissue

• Registration Number: DRKS00024753
• Lead Sponsor: niversität zu Lübeck, Institut für Sozialmedizin und Epidemiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-15
• Study Completion: 2022-05-09
• Results First Posted: 2024-03-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 405

Inclusion Criteria

We include patients aged 18 to 70 years with cardiovascular disease or musculoskeletal disorders and recruit them consecutively in equal numbers (200 patients each).

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Our study tests the diagnostic accuracy (sensitivity and specificity) of item 9 of the PHQ-9 and the total score of the PHQ-9 (Spritzer et al. 1999) for identifying suicidality. We use the C-SSRS (Posner et al. 2011) as the reference standard for the presence of suicidality. The C-SSRS is a standardized interview and is administered to the patient by trained staff. All study participants will be initially screened with the PHQ-9 at the beginning of rehabilitation. Subsequently, regardless of the screening result and without knowledge of this result, suicidality will be assessed with the C-SSRS. A positive score on the C-SSRS is defined as suicidal ideation with intent to act or recent suicidal behavior. Cutoffs for possible suicidality are defined as a score > 0 for item 9 of the PHQ-9 and a score > 14 for the total score of the PHQ-9.

Secondary Outcome Measures

Name	Time	Method
To evaluate the suicide prevention concept implemented in the rehabilitation facility, we record, among other things, the completeness of the intervention provided, patients’ perception of the intervention, and the number of people reached. To describe the sample, we also record age, gender, education, partnership, treatment diagnosis and comorbidity, and somatization and anxiety (Spritzer et al. 1999).